APA (7th ed.) Citation

Downing, N. S., Shah, N. D., Aminawung, J. A., Pease, A. M., Zeitoun, J., Krumholz, H. M., & Ross, J. S. (2017). Postmarket Safety Events Among Novel Therapeutics Approved by the US Food and Drug Administration Between 2001 and 2010. JAMA : the journal of the American Medical Association, 317(18), 1854-1863. https://doi.org/10.1001/jama.2017.5150

Chicago Style (17th ed.) Citation

Downing, Nicholas S., Nilay D. Shah, Jenerius A. Aminawung, Alison M. Pease, Jean-David Zeitoun, Harlan M. Krumholz, and Joseph S. Ross. "Postmarket Safety Events Among Novel Therapeutics Approved by the US Food and Drug Administration Between 2001 and 2010." JAMA : The Journal of the American Medical Association 317, no. 18 (2017): 1854-1863. https://doi.org/10.1001/jama.2017.5150.

MLA (9th ed.) Citation

Downing, Nicholas S., et al. "Postmarket Safety Events Among Novel Therapeutics Approved by the US Food and Drug Administration Between 2001 and 2010." JAMA : The Journal of the American Medical Association, vol. 317, no. 18, 2017, pp. 1854-1863, https://doi.org/10.1001/jama.2017.5150.